To include your compound in the COVID-19 Resource Center, submit it here.

Actelion warns on Tracleer competition in U.S.

Actelion Ltd. (SIX:ATLN) warned Thursday that U.S. sales growth of Tracleer bosentan may be affected by a less restrictive new label

Read the full 217 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE